Scott MacDonald
Hastings Entertainment
16 Papers
12 Citations
Scott MacDonald is an academic researcher from Hastings Entertainment. The author has contributed to research in topics: Hydromorphone & Opioid use disorder. The author has an hindex of 8, co-authored 16 publications. Previous affiliations of Scott MacDonald include Providence Health Care.
Chat about Author
Papers
Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review
Kirsten Marchand,Kirsten Marchand,Scott Beaumont,Scott Beaumont,Jordan Westfall,Scott MacDonald,Scott Harrison,David C. Marsh,Martin T. Schechter,Martin T. Schechter,Eugenia Oviedo-Joekes,Eugenia Oviedo-Joekes +11 more
TL;DR: A scoping review aimed to explore which PCC principles have been described and how they have defined and measured among people with substance-related disorders and revealed population and context-specific evidence regarding the defining characteristics of PCC-principles.
Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment.
Kirsten Marchand,Kirsten Marchand,Julie Foreman,Scott MacDonald,Scott Harrison,Martin T. Schechter,Martin T. Schechter,Eugenia Oviedo-Joekes,Eugenia Oviedo-Joekes +8 more
TL;DR: The core concept suggested that therapeutic relationships were fundamental to experiences of patient-centered care in iOAT, and when relationships were respectful and understanding, participants received individualized and holistic care iniOAT.
Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder.
Heather Palis,Heather Palis,Kirsten Marchand,Kirsten Marchand,Daphne Guh,Suzanne Brissette,Kurt Lock,Scott MacDonald,Scott Harrison,Aslam H. Anis,Michael Krausz,David C. Marsh,Martin T. Schechter,Martin T. Schechter,Eugenia Oviedo-Joekes,Eugenia Oviedo-Joekes +15 more
TL;DR: Despite presenting to treatment with vulnerabilities not faced to the same extent by men, at six-months women did not differ significantly from men in tested trial efficacy outcomes, which may be due to lack of adequate statistical power to detect meaningful effects.
Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report.
TL;DR: In this article, a 51-year-old male who was diagnosed with concurrent opioid and stimulant use disorder in an injectable opioid agonist treatment clinic in Vancouver, Canada was prescribed dextroamphetamine (a central nervous system stimulant) for the treatment of cocaine use disorder.
Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence
Eugenia Oviedo-Joekes,Eugenia Oviedo-Joekes,Heather Palis,Heather Palis,Daphne Guh,Kirsten Marchand,Kirsten Marchand,Suzanne Brissette,Kurt Lock,Scott MacDonald,Scott Harrison,Aslam H. Anis,Michael Krausz,David C. Marsh,Martin T. Schechter,Martin T. Schechter +15 more
TL;DR: Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-termopioid dependence are studied.
13